Skip to content
OpenCapital
Get started

ADMA Biologics ADMA Accrued bonuses

Accrued bonuses at other companies

ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
——

Other financials

Income statement

See full
Revenue$114.5M-0.3%
Gross profit$80.8M+32.2%
Operating income$58.3M+67.1%
Net income$45.3M+68.5%
EPS (diluted)$0.19+72.7%

Balance sheet

See full
Cash & equivalents$138.2M+92.9%
Total debt$204.4M+2,055%
Total equity$390.3M+4.5%
Total assets$665.2M+30.3%

Cash flow

See full
Operating cash flow$58.2M+396%
CapEx$2.5M-45.9%
Free cash flow$55.7M+329%

Valuation

See full
Market cap$2.01B-54.5%
Enterprise value$2.08B-52.5%
P/E12.2×-9.2×
P/S4×-5.7×

Profitability

See full
Gross margin61.3%+8.7pp
Operating margin42.1%+9.0pp
Net margin32.4%-12.6pp
FCF margin21.2%+1.4pp

Returns & leverage

See full
Return on equity43.3%-35.2pp
Debt / equity0.5×+0.5×
Current ratio7×+0.4×

Where this comes from

Reported directly by ADMA Biologics in its filing.

Tagged under the XBRL concept us-gaap:AccruedBonusesCurrent.

The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about ADMA Biologics's accrued bonuses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is ADMA Biologics's accrued bonuses?
ADMA Biologics (ADMA) reported accrued bonuses of $1.74M in Q1 2026.
How has ADMA Biologics's accrued bonuses changed year-over-year?
ADMA Biologics's accrued bonuses increased by 3.9% year-over-year, from $1.67M to $1.74M.
What is the long-term trend for ADMA Biologics's accrued bonuses?
Over 5 years (2020 to 2025), ADMA Biologics's accrued bonuses has grown at a 13.3% compound annual growth rate (CAGR), from $3.21M to $6.01M.
What does accrued bonuses mean?
This represents the current liability for employee performance-based bonuses that have been earned but not yet paid. It reflects the company's short-term compensation obligations and is a key indicator of accrued personnel costs.